Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolism-informed Care for Smoking Cessation
NCT03227679Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- May 2016
- Primary completion
- Oct 2016
- Modality
- Transdermal Patches, Small Molecules
01
Overview
Randomised, open-label trial of varenicline + nicotine patch, bupropion and nicotine patch in Tobacco Use Disorder (TUD) (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Theoretical Endorsement of Metabolism-Informed Care and Acceptance of Metabolism-Informed Care medication recommendation at 4 weeks. Started May 2016; status: completed.
02
Drugs
varenicline + nicotine patchbupropionnicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03227679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03227679.